Medical devices, healthcare technology and the business of care
PMA approval · P240009

Neuroguard IEP 3-in-1 Carotid Stent, Post-Dilation Balloon System with Integrated Embolic Protection

Contego Medical, Inc. · Decision date Oct 11, 2024

FDA DECISIONP240009

What did the FDA approve?

FDA records P240009 as an original PMA application. The recorded decision is approval, dated Oct 11, 2024.

FDA approval order statement

This Neuroguard IEP 3-in-1 Carotid Stent, Post-Dilation Balloon System with Integrated Embolic Protection is indicated for improving the carotid luminal diameter in subjects at high risk for adverse events from carotid endarterectomy who require carotid revascularization and meet the criteria outlined below: Patients with symptomatic stenosis of the common or internal carotid artery with >=50% as determined by angiography using NASCET methodology, or Patients with asymptomatic stenosis of the common or internal carotid artery with >=80% as determined by angiography using NASCET methodology; Patients with reference vessel diameters 4.0 8.0 mm. This device is also indicated for post-dilation of the stent component with simultaneous capture and removal of embolic material. The Neuroguard IEP System should always be used in conjunction with an available primary distal embolic protection device as described in the IFU.
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Oct 11, 2024

FDA source record

Regulatory record facts

Identifier
P240009
Regulatory pathway
Premarket approval application
Product code
NIM
Decision code
APPR
Decision date
Oct 11, 2024
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stent, carotid.

Product code
NIM
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P240009 received

    Application receipt date recorded by FDA.

  2. P240009 · FDA decision

    APPR

  3. P240009/S006 · Related supplement

    Neuroguard IEP 3-in-1 Carotid Stent, Post-Dilation Balloon System with Integrated Embolic Protection

Timeline entries are records held by MedtechLedger for P240009. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P240009

Product / regulatory recordCompanyPathwayDecision dateSource
Contego Medical, Inc.PMA supplementNov 4, 2026FDA

Explore the linked device profile

Other records with product code NIM

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Contego Medical, Inc.

Headquarters
Not reported
Brand website
contegomedical.com
FDA applicant address
3801 Lake Boone Trl., Suite 100, Raleigh, NC, 27607

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records